First-line systemic treatment: Can we do better than sorafenib?

Date 10 September 2017
Event ESMO 2017 Congress
Session ESMO COLLOQUIUM - Systemic treatment of unresectable hepatocellular carcinoma
Topics Cytotoxic agents
Hepatobiliary Cancers
Biological therapy
Presenter Arndt Vogel
Authors A. Vogel
  • Department Of Gastroenterology, Hepatology And Endocrinology, Hannover Medical School, 30625 - Hannover/DE